Loading…
Loading…
The KKR Income Opportunities Fund offers a 12.95% yield but has suffered NAV and price declines, raising concerns about distribution sustainability. KIO's portfolio blends floating-rate senior loans and fixed-rate junk bonds, positioning it to benefit modestly from potential Fed rate hikes. Recent performance has lagged peers, with the fund paying out more than it earns, leading to destructive distributions and NAV erosion.
Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora's ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis Pigmentosa Encinitas, California--(Newsfile Corp. - June 18, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) today announced preclinical data showing that KIO-300, part of the company's novel ion channel modulator platform, significantly suppressed seizure-associated electrophysiological activity in an ex vivo temporal lobe epilepsy (TLE) model. The findings were presented in a poster at the Epilepsy Foundation Pipeline Conference taking place June 18-19, 2026, in Leesburg, VA.
NEW YORK--(BUSINESS WIRE)--KKR Income Opportunities Fund (the “Fund”) (NYSE: KIO) today announced its monthly distributions of $0.1215 per common share, payable on the dates below. Based on the Fund's current share price of $11.26 per share (as of market close on June 5, 2026), the distributions represent an annualized distribution rate of 12.95% (calculated by annualizing the distribution amount and dividing it by the current price). The monthly distribution schedule is as follows for the mont.
KKR Income Opportunities (KIO) is rated 'Sell' due to high beta, credit risk, and limited upside in the current macro environment. KIO's portfolio is now 50% single-B, 20% CCC, with a 50/50 split between leveraged loans and high yield bonds, and 10% in CLOs. With credit spreads near historic lows and economic uncertainty from oil price spikes, KIO faces significant drawdown risk if spreads widen.
Shares of KKR Income Opportunities Fund (NYSE: KIO - Get Free Report) crossed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $11.21 and traded as high as $11.26. KKR Income Opportunities Fund shares last traded at $11.1050, with a volume of 85,627 shares changing hands. KKR
Encinitas, California--(Newsfile Corp. - April 14, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of KIO-301 in Nature Medicine. The publication adds clinical detail to a program aimed at restoring light responsiveness with a small molecule "photoswitch" in patients with the advanced inherited retinal disease, retinitis pigmentosa.
Seven high-yield fixed income CEFs—ARDC, BGH, BIT, GHY, KIO, OPP, WDI—currently trade at wider-than-average discounts, offering yields from 10% to 14%. Market fears over private credit and macroeconomic uncertainty have pressured prices, creating potential buying opportunities for long-term income investors. These funds diversify across senior loans, high-yield bonds, CLOs, and MBS, balancing floating and fixed-rate exposure to manage interest rate risk.
KKR Income Opportunities Fund (NYSE: KIO - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $11.71 and traded as low as $10.68. KKR Income Opportunities Fund shares last traded at $10.9950, with a volume of 247,565
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for KIO and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.